Sanara Fixed Asset Turnover from 2010 to 2025

SMTI Stock  USD 34.69  0.34  0.99%   
Sanara Medtech's Fixed Asset Turnover is decreasing with slightly volatile movements from year to year. Fixed Asset Turnover is predicted to flatten to 17.08. For the period between 2010 and 2025, Sanara Medtech, Fixed Asset Turnover quarterly trend regression had mean deviation of  34.69 and range of 146. View All Fundamentals
 
Fixed Asset Turnover  
First Reported
2010-12-31
Previous Quarter
17.98
Current Value
17.08
Quarterly Volatility
43.39888404
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sanara Medtech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanara Medtech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 M, Interest Expense of 235.7 K or Total Revenue of 78.5 M, as well as many indicators such as Price To Sales Ratio of 5.72, Dividend Yield of 0.0324 or PTB Ratio of 7.17. Sanara financial statements analysis is a perfect complement when working with Sanara Medtech Valuation or Volatility modules.
  
Check out the analysis of Sanara Medtech Correlation against competitors.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

Latest Sanara Medtech's Fixed Asset Turnover Growth Pattern

Below is the plot of the Fixed Asset Turnover of Sanara Medtech over the last few years. It is Sanara Medtech's Fixed Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanara Medtech's overall financial position and show how it may be relating to other accounts over time.
Fixed Asset Turnover10 Years Trend
Slightly volatile
   Fixed Asset Turnover   
       Timeline  

Sanara Fixed Asset Turnover Regression Statistics

Arithmetic Mean50.76
Geometric Mean35.50
Coefficient Of Variation85.50
Mean Deviation34.69
Median57.95
Standard Deviation43.40
Sample Variance1,883
Range146
R-Value(0.37)
Mean Square Error1,736
R-Squared0.14
Significance0.15
Slope(3.41)
Total Sum of Squares28,252

Sanara Fixed Asset Turnover History

2025 17.08
2024 17.98
2023 19.98
2022 20.62
2021 11.82
2020 13.6
2019 14.89

About Sanara Medtech Financial Statements

Investors use fundamental indicators, such as Sanara Medtech's Fixed Asset Turnover, to determine how well the company is positioned to perform in the future. Although Sanara Medtech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Fixed Asset Turnover 17.98  17.08 

Currently Active Assets on Macroaxis

When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:
Check out the analysis of Sanara Medtech Correlation against competitors.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
9.241
Quarterly Revenue Growth
0.352
Return On Assets
(0.05)
Return On Equity
(0.20)
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.